SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
- DOI
- 10.1016/j.cell.2020.02.052
- Published
- 2020 Apr 16
- Container
- Cell
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cell.2020.02.052,
title = {SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.},
author = {Hoffmann M and Kleine-Weber H and Schroeder S and Krüger N and Herrler T and Erichsen S and Schiergens TS and Herrler G and Wu NH and Nitsche A and Müller MA and Drosten C and Pöhlmann S},
year = {2020},
journal = {Cell},
doi = {10.1016/j.cell.2020.02.052},
url = {https://doi.org/10.1016/j.cell.2020.02.052}
}RIS
TY - JOUR TI - SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. AU - Hoffmann M AU - Kleine-Weber H AU - Schroeder S AU - Krüger N AU - Herrler T AU - Erichsen S AU - Schiergens TS AU - Herrler G AU - Wu NH AU - Nitsche A AU - Müller MA AU - Drosten C AU - Pöhlmann S PY - 2020 JO - Cell DO - 10.1016/j.cell.2020.02.052 UR - https://doi.org/10.1016/j.cell.2020.02.052 ER -
APA
M, H., H, K., S, S., N, K., T, H., S, E., TS, S., G, H., NH, W., A, N., MA, M., C, D., & S, P. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.. Cell. https://doi.org/10.1016/j.cell.2020.02.052
Source records
- pubmed · retrieved 2026-09-24T20:07:00.290Z